Role of sulfiredoxin in systemic diseases influenced by oxidative stress

Sulfiredoxin is a recently discovered member of the oxidoreductases family which plays a crucial role in thiol homoeostasis when under oxidative stress. A myriad of systemic disorders have oxidative stress and reactive oxygen species as the key components in their etiopathogenesis. Recent studies have evaluated the role of this enzyme in oxidative stress mediated diseases such as atherosclerosis, chronic obstructive pulmonary disease and a wide array of carcinomas. Its action is responsible for the normal functioning of cells under oxidative stress and the promotion of cell survival in cancerous cells. This review will highlight the cumulative effects of sulfiredoxin in various systemic disorders with a strong emphasis on its target activity and the factors influencing its expression in such conditions.

• Publication year

  2014

• Venue

  Redox Biology

• Publication date

  2014-09-16

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.redox.2014.09.002PMID 25460739PMCID 4215520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of mitochondria in NLRP3 inflammasome activation.

  2018cited by this paper
• DioxolaneA3-phosphatidylethanolamines are generated by human platelets and stimulate neutrophil integrin expression

  2017cited by this paper
• Nuclear Nrf2 expression is related to a poor survival in pancreatic adenocarcinoma.

  2014cited by this paper
• Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.

  2014cited by this paper
• Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis.

  2013cited by this paper
• Protective effect of rutin on the antioxidant genes expression in hypercholestrolemic male Westar rat

  2013cited by this paper
• Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation.

  2013influential reference
• Periovulatory expression of hydrogen peroxide-induced sulfiredoxin and peroxiredoxin 2 in the rat ovary: gonadotropin regulation and potential modification.

  2012cited by this paper
• Nuclear factor erythroid-derived 2-like 2 (Nrf2) and DJ1 are prognostic factors in lung cancer.

  2012cited by this paper
• Nrf2 activation prevents cadmium-induced acute liver injury.

  2012influential reference
• Peroxiredoxin III and Sulfiredoxin Together Protect Mice from Pyrazole-Induced Oxidative Liver Injury

  2012cited by this paper
• Activation of antioxidant response element (ARE)-dependent genes by roasted coffee extracts.

  2012cited by this paper
• Sulfiredoxin redox-sensitive interaction with S100A4 and non-muscle myosin IIA regulates cancer cell motility.

  2012cited by this paper
• Feedback control of adrenal steroidogenesis via H2O2-dependent, reversible inactivation of peroxiredoxin III in mitochondria.

  2012influential reference
• Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation.

  2012cited by this paper
• Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma.

  2011cited by this paper
• Reactive oxygen species are indispensable in ovulation

  2011cited by this paper
• A role for mitochondria in NLRP3 inflammasome activation

  2011cited by this paper
• Maesopsin 4-O-beta-D-glucoside, a natural compound isolated from the leaves of Artocarpus tonkinensis, inhibits proliferation and up-regulates HMOX1, SRXN1 and BCAS3 in acute myeloid leukemia.

  2011cited by this paper
• Sulfiredoxin Protects Mice from Lipopolysaccharide-Induced Endotoxic Shock

  2011cited by this paper
• Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells

  2011cited by this paper
• Nitric oxide activates an Nrf2/sulfiredoxin antioxidant pathway in macrophages.

  2011cited by this paper
• Sulfiredoxin Protein Is Critical for Redox Balance and Survival of Cells Exposed to Low Steady-state Levels of H2O2*♦

  2011influential reference
• Nuclear factor E2-related factor 2 Dependent Overexpression of Sulfiredoxin and Peroxiredoxin III in Human Lung Cancer

  2011cited by this paper
• Nrf2 is essential for cholesterol crystal‐induced inflammasome activation and exacerbation of atherosclerosis

  2011cited by this paper
• Concerted action of sulfiredoxin and peroxiredoxin I protects against alcohol‐induced oxidative injury in mouse liver

  2011cited by this paper
• Sulfiredoxin–Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling

  2011cited by this paper
• Redox Regulation of Lipopolysaccharide-mediated Sulfiredoxin Induction, Which Depends on Both AP-1 and Nrf2*

  2010cited by this paper
• Irreversible Inactivation of Glutathione Peroxidase 1 and Reversible Inactivation of Peroxiredoxin II by H2O2 in Red Blood Cells

  2010cited by this paper
• Nonresolving inflammation.

  2010cited by this paper
• The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth.

  2009cited by this paper
• Induction of Sulfiredoxin via an Nrf2-Dependent Pathway and Hyperoxidation of Peroxiredoxin III in the Lungs of Mice Exposed to Hyperoxia

  2009cited by this paper
• Macrophage heterogeneity in atherosclerotic plaques

  2009cited by this paper
• Sulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III*

  2009cited by this paper
• Copper activation of NF-kappaB signaling in HepG2 cells.

  2009cited by this paper
• Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs.

  2009cited by this paper
• Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies

  2008influential reference
• The in vivo gene expression signature of oxidative stress.

  2008cited by this paper
• Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses

  2008cited by this paper
• Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H‐1,2‐dithiole‐3‐thione

  2008cited by this paper
• Identification of Intact Protein Thiosulfinate Intermediate in the Reduction of Cysteine Sulfinic Acid in Peroxiredoxin by Human Sulfiredoxin*

  2008cited by this paper
• Protein cysteine sulfinic acid reductase (sulfiredoxin) as a regulator of cell proliferation and drug response

  2008influential reference
• Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance.

  2007cited by this paper
• Transcriptional response of pancreatic beta cells to metabolic stimulation: large scale identification of immediate-early and secondary response genes

  2007cited by this paper
• Regulation of Peroxiredoxins by Nitric Oxide in Immunostimulated Macrophages*

  2007cited by this paper
• A novel role for human sulfiredoxin in the reversal of glutathionylation.

  2006cited by this paper
• Oxidation of a Eukaryotic 2-Cys Peroxiredoxin Is a Molecular Switch Controlling the Transcriptional Response to Increasing Levels of Hydrogen Peroxide*

  2005cited by this paper
• Sulfiredoxin: a potential therapeutic agent?

  2005cited by this paper
• Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3.

  1994cited by this paper
• Peroxynitrite formation from macrophage-derived nitric oxide.

  1992cited by this paper
• Edinburgh Research Explorer Transcriptional regulation of the AP-1 and Nrf2 target gene sulfiredoxin

  year unknowncited by this paper

• Comparative Analysis of Immune Response Genes Induced by a Virulent or Attenuated Strain of Babesia bigemina

  2025cites this paper
• Sulfiredoxin stimulates luteinization in vitro by promoting progesterone production in rats

  2025cites this paper
• Sulfiredoxin levels in gingival crevicular fluid: A new antioxidant defence system- case control study

  2025cites this paper
• Cysteine sulfinic acid and sulfinylated peptides

  2025cites this paper
• Therapeutic potential of cell-permeable PEP-1-Srxn1 in mitigating oxidative and ischemic damage in the hippocampus.

  2025cites this paper
• The Role of S-Glutathionylation in Health and Disease: A Bird’s Eye View

  2024cites this paper
• CRL3Keap1 E3 ligase facilitates ubiquitin-mediated degradation of oncogenic SRX to suppress colorectal cancer progression

  2024cites this paper
• The de-sulfinylation enzyme sulfiredoxin-1 attenuates hepatic stellate cell activation and liver fibrosis by modulating the PTPN12-NLRP3 axis.

  2024cites this paper
• Comparative Evaluation of Gingival Crevicular Fluid Sulfiredoxin Levels in Patients with Periodontitis Prior and after Periodontal Therapy: A Prospective Clinical Trial

  2024cites this paper
• Iron metabolism and ferroptosis: A pathway for understanding preeclampsia.

  2023cites this paper
• Ferroptosis in the colon epithelial cells as a therapeutic target for ulcerative colitis

  2023cites this paper
• Comparative analysis of sulfiredoxin and total oxidative stress levels in diabetic individuals with periodontitis-a case-control study.

  2022cites this paper
• Association of SRXN1 Receptor Gene Polymorphism with Susceptibility to Periodontitis

  2022cites this paper
• Sulfiredoxin-1 protects retinal ganglion cells from high glucose-induced oxidative stress and inflammatory injury by potentiating Nrf2 signaling via the Akt/GSK-3β pathway.

  2021cites this paper
• Terminalia chebula Mediated Silver Nanoparticles and Its Antibacterial Activity against Oral Pathogens

  2021cites this paper
• In vitro Anti Inflammatory Activity of Abies webbiana Using Albumin Denaturation Assay

  2021cites this paper
• SRXN1 stimulates hepatocellular carcinoma tumorigenesis and metastasis through modulating ROS/p65/BTG2 signalling

  2020cites this paper
• Chapter 6: Thioredoxin system

  2020cites this paper
• Identifying and Characterizing Stress Pathways of Concern for Consumer Safety in Next-Generation Risk Assessment

  2020cites this paper
• Targeting the Redox Landscape in Cancer Therapy

  2020cites this paper
• Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma

  2020cites this paper
• Cyclic O3 exposure synergizes with aging leading to memory impairment in male APOE ε3, but not APOE ε4, targeted replacement mice.

  2019cites this paper
• Chemical Proteomics Reveals New Targets of Cysteine Sulfinic Acid Reductase

  2018cites this paper
• Regulation of oxidoreductase enzymes during inflammation

  2018cites this paper
• Short‐ and long‐term gene expression profiles induced by inhaled TiO2 nanostructured aerosol in rat lung

  2018cites this paper
• Comparative estimation of sulfiredoxin levels between chronic periodontitis and healthy patients – A case‐control study

  2018cites this paper
• Sulfiredoxin involved in the protection of peroxiredoxins against hyperoxidation in the early hyperglycaemia

  2017cites this paper
• Expression of thioredoxin, 8Hydroxy-deguanosine and peroxiredoxins in placental tissues.

  2017cites this paper
• Sulfiredoxin may promote metastasis and invasion of cervical squamous cell carcinoma by epithelial–mesenchymal transition

  2017cites this paper
• Application of Clinical Bioinformatics

  2016cites this paper
• Gene expression profile of oxidative stress and antioxidant defense in lung tissue of patients exposed to sulfur mustard.

  2016cites this paper
• Oxidative stress and altered expression of peroxiredoxin genes family (PRDXS) and sulfiredoxin-1 (SRXN1) in human lung tissue following exposure to sulfur mustard

  2016cites this paper
• Role of sulfiredoxin interacting proteins in lung cancer development

  2016cites this paper
• Targeted Metabolomics: The Next Generation of Clinical Chemistry!

  2016cites this paper